Skip to main content
. Author manuscript; available in PMC: 2007 Aug 24.
Published in final edited form as: Prostate. 2005 Nov 1;65(3):216–221. doi: 10.1002/pros.20286

TABLE I.

Distribution of Serum fPSA, tPSA, cPSA, and Percent fPSA Values at the Three Rounds of Screening

Median (25th–75th centiles)
Group Year of screening fPSA (ng/ml) tPSA (ng/ml) cPSA (ng/ml) %fPSA
A 1995–1996 0.15 (0.12–0.20) 0.45 (0.35–0.59) 0.28 (0.20–0.40) 34.5 (26.2–43,4)
1997–1998 0.15 (0.11–0.19) 0.48 (0.35–0.62) 0.31 (0.22–0.43) 31.2 (24.0–39.7)
2001–2002 0.15 (0.11–0.19) 0.43 (0.34–0.53) 0.27 (0.20–0.35) 35.8 (27.8–43.0)
B 1995–1996 0.19 (0.14–0.25) 0.58 (0.42–0.79) 0.38 (0.25–0.55) 32.9 (25.0–42.0)
1997–1998 0.18 (0.13–0.25) 0.62 (0.45–0.79) 0.41 (0.28–0.56) 31.3 (24.3–38.7)
2001–2002 0.19 (0.14–0.16) 0.61 (0.43–0.78) 0.39 (0.27–0.52) 33.3 (26.1–41.1)
C 1995–1996 0.29 (0.23–0.37) 1.05 (0.84–1.35) 0.75 (0.56–1.02) 27.5 (21.5–34.6)
1997–1998 0.30 (0.23–0.40) 1.15 (0.93–1.46) 0.84 (0.63–1.10) 26.2 (20.6–33.1)
2001–2002 0.36 (0.28–0.46) 1.36 (1.15–1.63) 0.98 (0.83–1.21) 26.5 (20.7–32.7)

Group A represents men with tPSA ≤ 0.61 ng/ml, group B men with tPSA ≤ 0.99 ng/ml, and group C men with tPSA 1.00–1.99 ng/ml, in 2001–2002.

Calculated parameters are shown in italics.